AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F1207-F1212, 2008. First published August 20, 2008; doi:10.1152/ajprenal.90243.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/F1207    most recent
90243.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, Y.
Right arrow Articles by Carretero, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, Y.
Right arrow Articles by Carretero, O. A.

Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF)

YiLin Ren, Martin A. D'Ambrosio, Hong Wang, Ruisheng Liu, Jeffrey L. Garvin, and Oscar A. Carretero

Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, Michigan

Submitted 7 April 2008 ; accepted in final form 12 August 2008

Tubuloglomerular feedback (TGF) is the mechanism by which the macula densa (MD) senses increases in luminal NaCl concentration and sends a signal to constrict the afferent arteriole (Af-Art). The kidney expresses constitutively heme oxygenase-2 (HO-2) and low levels of HO-1. HOs release carbon monoxide (CO), biliverdin, and free iron. We hypothesized that renal HOs inhibit TGF via release of CO and biliverdin. Rabbit Af-Arts and attached MD were simultaneously microperfused in vitro. The TGF response was determined by measuring Af-Art diameter before and after increasing NaCl in the MD perfusate. When HO activity was inhibited by adding stannous mesoporphyrin (SnMP) to the MD perfusate, the TGF response increased from 2.1 ± 0.2 to 4.1 ± 0.4 µm (P = 0.003, control vs. SnMP, n = 7). When a CO-releasing molecule, (CORM-3; 50 µM), was added to the MD perfusate, the TGF response decreased by 41%, from 3.6 ± 0.3 to 2.1 ± 0.2 µm (P < 0.001, control vs. CORM-3, n = 12). When CORM-3 at 100 µM was added to the perfusate, it completely blocked the TGF response, from 4.2 ± 0.4 to –0.2 ± 0.3 µm (P < 0.001, control vs. CORM-3, n = 6). When biliverdin was added to the perfusate, the TGF response decreased by 79%, from 3.4 ± 0.3 to 0.7 ± 0.4 µm (P = 0.001, control vs. biliverdin, n = 6). The effects of SnMP and CORM-3 were not blocked by inhibition of nitric oxide synthase. We concluded that renal HO inhibits TGF probably via release of CO and biliverdin. HO regulation of TGF is a novel mechanism that could lead to a better understanding of the control of renal microcirculation and function.

carbon monoxide; biliverdin; afferent arteriole; macula densa



Address for reprint requests and other correspondence: O. A. Carretero, Div. of Hypertension and Vascular Research, Henry Ford Hospital, 2799 Grand Blvd., Detroit, MI 48202 (e-mail: ocarret1{at}hfhs.org)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.